Assaf Barnea is the Managing Partner of Sanara Ventures, an Israeli healthcare innovation fund he has led since its 2015 inception. See contact routes.
Assaf Barnea is the Managing Partner of Sanara Ventures, an Israeli healthcare innovation fund he has led since its 2015 inception, backed by Philips and Teva. His investment thesis focuses on early-stage Digital Health, Medical Devices, and Bio-Convergence companies, primarily within Israel and the global healthcare market. Sanara typically targets A- and B-round investments, with Barnea serving as CEO of the Sanara Investment Group that oversees the venture incubator. Notable portfolio companies include TailorMed, which helps US patients minimize deductibles, and CVAID, a stroke diagnosis platform, alongside his chairmanship at Lydus Medical and Imedis AI. Barnea distinguishes his approach by championing "bio-convergence"—the integration of biology with data and devices—and actively promotes Israeli life science exports through his role chairing the Israel Export Institute’s Life Science Board. He also co-founded the World Bank’s TechEmerge program, connecting global healthcare startups with corporations in emerging economies, and frequently speaks on digital health commercialization at international conferences.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Ra'anana.
Investors like Assaf Barnea · Full investor directory · Investor access · Company funding database